SLC2A7 antibody (C-Term)
Quick Overview for SLC2A7 antibody (C-Term) (ABIN595290)
Target
See all SLC2A7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Recognizes human GLUT7.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide corresponding to 12aa from human GLUT7, C-terminal, cytoplasmic domain (KLH).
Type of Immunogen: Synthetic peptide - KLH conjugated -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: ELISA (0.5 - 1 μg/mL), WB (1 - 5 μg/mL)
Usage: Suitable for use in Western Blot and ELISA. Western Blot: 1-5 μg/mL (chemiluminescence). ELISA: 0.5-1 μg/mL. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 0.1 mL sterile PBS
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS, 0.1 % BSA.
-
Handling Advice
- Aliquot to Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
-
- SLC2A7 (Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 7 (SLC2A7))
-
Alternative Name
- SLC2A7 / GLUT7
-
Background
-
Name/Gene ID: SLC2A7
Synonyms: SLC2A7, Glucose transporter type 7, GLUT-7, GLUT7 -
Gene ID
- 155184
-
UniProt
- Q6PXP3
Target
-